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1.22, 1.00, 0.90, 0.85, 0.83, 0.90, 1.09, 1.54, and 3.21.
CONCLUSIONS: The five MH5 items fit the Rasch
model very well. Classic summative scoring tends to com-
press the measurement scale at its extremities, by assign-
ing scores that are too low at the high end, and too high
at the low end. Rasch scoring may render MH5 more
sensitive to changes among well populations and among
the very sick.
MUSCULOSKELETAL DISORDERS
MS1
COST-EFFECTIVENESS OF INTERVENTIONS 
FOR LATERAL EPICONDYLITIS: RESULTS FROM 
A RANDOMIZED CONTROLLED TRIAL IN 
PRIMARY CARE
Korthals-de Bos IBC, Smidt N, Tulder M, Bouter L
Vrije Universiteit Amsterdam, Amsterdam, Netherlands
OBJECTIVES: In 1997, the Dutch College of General
Practitioners in the Netherlands issued guidelines which
recommend a wait-and-see policy for patients with lateral
epicondylitis. However, these guidelines are not evidence-
based. This paper presents the results of an economic
evaluation in conjunction with a randomized controlled
trial to evaluate the effects of three interventions for pa-
tients with lateral epicondylitis. METHODS: 185 Pa-
tients with pain at the lateral side of the elbow were ran-
domized to one of three interventions: a wait-and-see
policy (n  59), corticosteroid injections (n  62) or
physiotherapy (n  64). Clinical outcomes included gen-
eral improvement, pain during the day, elbow disability
and quality of life (EuroQol). Direct and indirect costs
were measured by means of cost diaries over a period of
12 months. Differences in mean costs between groups
were evaluated by applying non-parametric bootstrap
techniques. RESULTS: After 12 months, the success rate
in the physiotherapy group (91%) was significantly
higher than in the injection group (69%), but only
slightly higher than in the wait-and-see group (83%).
With regard to pain during the day and elbow disability,
physiotherapy differed significantly over time, comparing
to injection group, for these clinical outcomes. The mean
total costs per patient for corticosteroid injections were
Euro 430, compared to Euro 631 for the wait-and-see
policy and Euro 921 for physiotherapy. These differences
were statistically significant for corticosteroid injections
compared to physiotherapy. The cost-effectiveness ratios
showed no statistically significant differences between the
three groups. The cost-utility ratio comparing physio-
therapy and wait-and-see policy was 34,461 (1,982;
9,535,522); the other cost-utility ratios were not statisti-
cally significant. CONCLUSIONS: The results of this
economic evaluation provide no reason to update or
amend the Dutch guidelines for general practitioners,
which recommend a wait-and-see policy for patients with
lateral epicondylitis.
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RAPOLO, A LONGITUDINAL STUDY OF 
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OBJECTIVES: To evaluate the responsiveness of the SF-
36 subscales, the generic physical (PCS) and mental
(MCS) components of the SF-36, and the SF-36 Arthritis-
Specific Health Index (ASHI) to changes in disability
measured by the Health Assessment Questionnaire
(HAQ) in RAPOLO. METHODS: We identified 388 par-
ticipants from RAPOLO, a longitudinal, observational
study of RA, who had repeated measures of arthritis spe-
cific function (HAQ and ASHI) and general function (SF-
36). We categorized patients into three groups according
to HAQ score—(1) stable, (2) declined (increase in HAQ
score of 0.25) and (3) improved (a decline in HAQ
score of 0.25). For each group we calculated Guyatt’s
statistic—a measure of responsiveness to change. The
larger the absolute value of Guyatt’s statistic, the greater
the responsiveness to change. RESULTS: Cohort is 79%
female; mean disease duration is 13.2 yrs; mean age is 55
yrs. There were 286 participants who had no change in
HAQ score. Guyatt’s statistic ranged between 0.04 to
0.17 (Social Functioning). There were 52 participants
who declined. The Guyatt’s statistics for the SF-36
ranged from 0.11 (Role Emotional) to 1.88 (Role-Physi-
cal). There were 46 participants who improved in HAQ
score. The Guyatt’s statistic ranged from 0.14 (Mental
Component Summary Score) to 1.58 (Role-Physical).
CONCLUSIONS: Statistics less than 0.3 indicate no re-
sponsiveness to change, statistics 0.5 reflect responsive-
ness to change. The physical subscales of the SF-36, the
PCS, and the ASHI were moderately to highly responsive
to change in HAQ score. The emotional subscales were
not responsive to change in disability.
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CORRELATION OF A GENERIC HEALTH-
RELATED QUALITY OF LIFE QUESTIONNAIRE 
AND SELF-ADMINISTERED RHEUMATOID 
ARTHRITIS DISEASE ACTIVITY INSTRUMENT
Kim SS, Drabinski AM, Williams GR, Formica CA
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BACKGROUND: Health-related quality of life (HR-
QOL) measures have been used to study the impact of
disease activity in patients with rheumatoid arthritis
(RA). The objective of this study was to evaluate the cor-
relation between SF-36 scales, physical function (PF), role
physical (RP) and bodily pain (BP) and Rapid Assessment
of Disease Activity in Rheumatology (RADAR). METH-
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ODS: Baseline data was analyzed from the Study of New
Onset Rheumatoid Arthritis (S.O.N.O.R.A.SM), a 5-year
prospective, longitudinal, inception cohort study to docu-
ment long-term functional, clinical, and humanistic out-
comes and patterns of treatment in patients with new
onset rheumatoid arthritis. Baseline data collection con-
sisted of RADAR and SF-36 via telephone interviews by
trained interviewers. To assess the correlation, Pearson
product moment correlation coefficients were calculated.
RESULTS: One hundred thirty-one patients completed
the baseline survey. Mean age of the sample was 56
years; 78% were female; 82% were Caucasian. SF-36’s
PF, RP, and BP scales had means of 54 (SE  0.02), 31
(SE  0.03), and 47 (SE  0.02), respectively. Mean
scores for RADAR items were 7.2 (SE  0.22) for “ar-
thritis activity over the past 6 months (AA6M)”, 4.9
(SE  0.23) for “arthritis activity today (AAT)”, 4.2 (SE 
0.22) for “arthritis pain today (APT)”, and 2.6 (SE 
0.15) for “morning stiffness today (MST)”. SF-36’s PF
scale correlated with AA6M (r  0.39, p  0.001), AAT
(r  0.49, p  0.001), APT (r  0.51, p  0.001), and
MST (r  0.40, p  0.001). SF-36’s RP scale correlated
with AA6M (r  0.37, p  0.001), AAT (r  0.38, p 
0.001), APT (r  0.44, p  0.001), and MST (r  0.33,
p  0.001). SF-36’s BP scale correlated with AA6M (r 
0.50, p  0.001), AAT (r  0.48, p  0.001), APT (r 
0.59, p  0.001), and MST (r  0.42, p  0.001). CON-
CLUSION: The SF-36’s BP domain resulted in the high-
est correlation with RADAR items. The APT item of
RADAR had the highest correlation with all three do-
mains of SF-36. These results suggest that the level of
bodily pain is indicative of functioning and well-being of
patients.
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An important weakness of economic models in the field
of osteoporosis has been the dependence on assumptions
or expert judgments rather than empirical estimates for
the utility values of key health events associated with os-
teoporosis. OBJECTIVES: This paper seeks to identify
the best available utility estimates for health states associ-
ated with osteoporosis and make recommendations about
their use. METHODS: This review has been based on a
systematic search of the main literature databases. Stud-
ies meeting the inclusion criteria have been reviewed in
terms of the appropriateness of the valuation technique,
the validity of the descriptive system (where one was
used), the number and type of respondents and overall
study quality. RESULTS: Twenty-three estimates of health
state values (HSVs) were found across four conditions
from five studies. These empirical estimates were found
to differ significantly from the commonly used assump-
tions in published economic models of interventions or
osteoporosis, but with a wide variation between esti-
mates for the same state (0.32 to 0.80) for vertebral frac-
ture states). This variation can be partly explained by
differences in the valuation technique, health state de-
scriptions and the background and perspective of the re-
spondent, and leaves considerable scope for discretion
that could be abused. There are also problems in apply-
ing values obtained from these studies to the populations
being examined in economic models and a particular dif-
ficulty in predicting the HSV in those who avoid a frac-
ture as a result of an intervention. CONCLUSION: The
review recommends a set of HSVs as part of a reference
case for use in economic models. Due to the paucity of
good quality estimates in this area, further recommenda-
tions are made regarding the design of future studies to
collect HSVs relevant to economic models.
RESPIRATORY DISORDERS/DISEASES
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ASTHMA: A COMPARISON OF SYMPTOM-FREE 
TIME AND MULTI-ATTRIBUTE SCALE
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1Zynx Health Inc.—a subsidiary of Cedars-Sinai Health System, 
Beverly Hills, CA, USA; 2University of Washington, Seattle, 
WA, USA
INTRODUCTION: Most current asthma outcome mea-
sures are either not sensitive enough to detect changes
caused by interventions or not broad enough to cover all
health domains affected by the disease. OBJECTIVE: To
develop a comprehensive measure of health outcomes for
children with asthma that is in compliance with the rec-
ommendations of the U.S. Panel on Cost-Effectiveness in
Health and Medicine, and compare health outcomes esti-
mated with that measure to those estimated with the
symptom-free day, the most commonly used measure.
METHODS: 1) Develop a multi-attribute Pediatric
Asthma Health Outcome Measure, PAHOM, that as-
sesses the impact of asthma on children’s symptoms,
emotions, and physical activity; 2) Collect data on prefer-
ence weights (Ui) for asthma health states from 101
adults using the standard gamble technique; 3) Collect
data on the incidence of health states (Pi) from 72 chil-
dren with asthma using PAHOM calendar; and 4) Calcu-
late the expected utility by summing all of (Ui*Pi). The
expected utility can be used as a proxy of health outcome
if it is assumed that health outcomes of these children are
constant for the remaining life years. RESULTS: On a
scale ranging from zero to one, where perfect health had
a score of one, the average utility of pediatric asthma pa-
tients in the study was 0.900 when measured with the
PAHOM, compared to 0.955 when measured with a
symptom-free day. CONCLUSION: PAHOM, a more
comprehensive measure of health outcomes than symp-
